Mark Ware

Mark is responsible for leading the global development of business for our Clinical Trial Services. This includes the advancement and implementation of key enhancements such as DDLD (Demand Driven Labelling and Distribution), specialized workstreams such as our Biosimilar sourcing strategy and stand alone offerings such as an outsourcing solution for IISs (Investigator Initiated Studies).

With over 17 years' experience in the Pharma industry Mark's prior roles have included working as a Senior Business Analyst for a Pharmaceutical consultancy, leading business development for a clinical trial cognition assessment firm and running the Medical Directors' service for a Pharma benchmarking organization. Mark joins Clinigen from Idis where he was Head of Clinical Trial Procurement.